human | Q5 |
P2038 | ResearchGate profile ID | Ajay-Kirtane |
P1153 | Scopus author ID | 6603083771 |
P108 | employer | Columbia University Irving Medical Center | Q2415975 |
P106 | occupation | researcher | Q1650915 |
P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
Q59217492 | 1003 TIMI myocardial perfusion grade predicts infarct size, perimeter and border zone following STEMI |
Q43284723 | 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents |
Q43610839 | 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of p |
Q91034613 | A Need For Long-Term Results of LMCA-CTO-PCI |
Q64905568 | A Survey of Interventional Cardiologists' Attitudes and Beliefs About Public Reporting of Percutaneous Coronary Intervention. |
Q39344608 | A Test in Context: Fractional Flow Reserve: Accuracy, Prognostic Implications, and Limitations |
Q38119880 | A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events |
Q47264632 | A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs |
Q47100525 | A randomised comparison of Conventional versus Intentional straTegy in patients with high Risk prEdiction of Side branch OccLusion in coronary bifurcation interVEntion: rationale and design of the CIT-RESOLVE trial |
Q44178322 | A randomized comparison of novel biodegradable polymer- and durable polymer-coated cobalt-chromium sirolimus-eluting stents |
Q43163646 | A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial |
Q43049810 | A risk score to predict bleeding in patients with acute coronary syndromes |
Q57741455 | ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization |
Q38017132 | ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: American College of Cardiology Foundation Appropriate Use Criteria Task Force Society for Cardiovascular Angiography and Interventi |
Q38009479 | ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiograp |
Q60925334 | APPLICATION AND OUTCOMES OF THE HYBRID APPROACH TO CHRONIC TOTAL OCCLUSION PERCUTANEOUS CORONARY INTERVENTION: AN UPDATE FROM A CONTEMPORARY MULTICENTER US REGISTRY |
Q46697429 | Accreditation and funding for a 24-month advanced interventional cardiology fellowship program: A call-to-action for optimal training of the next generation of interventionalists |
Q90759459 | Accuracy of Fractional Flow Reserve Derived From Coronary Angiography |
Q33413684 | Acquired thrombocytopenia after transcatheter aortic valve replacement: clinical correlates and association with outcomes. |
Q94545562 | Active SB-P Versus Conventional Approach to the Protection of High-Risk Side Branches: The CIT-RESOLVE Trial |
Q43758526 | Acute left main coronary occlusion caused by stent fracture, peri-stent aneurysm formation, and very-late stent thrombosis: revisiting the dark side of drug-eluting stents |
Q51253332 | Adherence to American College of Cardiology/American Heart Association guidelines for the management of anticoagulation in patients with mechanical valves undergoing elective outpatient procedures. |
Q46822443 | Administration of intracoronary eptifibatide during ST-elevation myocardial infarction |
Q92529195 | Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study |
Q85227295 | Age-related effects of smoking on culprit lesion plaque vulnerability as assessed by grayscale and virtual histology-intravascular ultrasound |
Q93364923 | Algorithmic solutions to common problems encountered during chronic total occlusion angioplasty: The algorithms within the algorithm |
Q91279201 | An Updated Healthcare System-Wide Clinical Pathway for Managing Patients With Chest Pain and Acute Coronary Syndromes |
Q38962250 | An Updated Protocol for Evaluating Chest Pain and Managing Acute Coronary Syndromes |
Q53127895 | An angiographic tool based on Visual estimation for Risk prEdiction of Side branch OccLusion in coronary bifurcation interVEntion: the V-RESOLVE score system. |
Q51015163 | An angiographic tool for risk prediction of side branch occlusion in coronary bifurcation intervention: the RESOLVE score system (Risk prEdiction of Side branch OccLusion in coronary bifurcation interVEntion). |
Q35787402 | Analysis of early out-of hospital mortality after transcatheter aortic valve implantation among patients with aortic stenosis successfully discharged from the hospital and alive at 30 days (from the placement of aortic transcatheter valves trial). |
Q45238086 | Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction |
Q46475076 | Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention |
Q51545745 | Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: Insights from the ADAPT-DES study. |
Q28199569 | Angiographically evident thrombus following fibrinolytic therapy is associated with impaired myocardial perfusion in STEMI: a CLARITY-TIMI 28 substudy |
Q34487339 | Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors |
Q87943993 | Aortic Valve Stenosis |
Q38223702 | Aortic stenosis and coronary artery disease: what do we know? What don't we know? A comprehensive review of the literature with proposed treatment algorithms |
Q36011391 | Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry. |
Q96160509 | Approach to Acute Cardiovascular Complications in COVID-19 Infection |
Q48908278 | Approaches to percutaneous coronary intervention of right coronary artery chronic total occlusions: insights from a multicentre US registry |
Q85221556 | Are the current American College of Cardiology/American Heart Association stable ischemic heart disease guidelines too conservative? |
Q93061032 | Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study) |
Q92843402 | Association Between Transcatheter Aortic Valve Replacement and Early Postprocedural Stroke |
Q86606555 | Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial |
Q80333403 | Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relat |
Q36357689 | Association of Patient-Reported Health Status With Long-Term Mortality After Transcatheter Aortic Valve Replacement: Report From the STS/ACC TVT Registry |
Q90960309 | Association of Physician Variation in Use of Manual Aspiration Thrombectomy With Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The National Cardiovascular Data Registry CathPCI Registry |
Q90242440 | Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement |
Q49387582 | Association of Stress Test Risk Classification With Health Status After Chronic Total Occlusion Angioplasty (from the Outcomes, Patient Health Status and Efficiency in Chronic Total Occlusion Hybrid Procedures [OPEN-CTO] Study). |
Q40127504 | Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction |
Q38377257 | Association of Transcatheter Aortic Valve Replacement With 30-Day Renal Function and 1-Year Outcomes Among Patients Presenting With Compromised Baseline Renal Function: Experience From the PARTNER 1 Trial and Registry |
Q52675179 | Association of Tricuspid Regurgitation With Transcatheter Aortic Valve Replacement Outcomes: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. |
Q42646459 | Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients |
Q46780330 | Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study). |
Q81319198 | Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy |
Q80507974 | Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction |
Q80538474 | Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction |
Q44953154 | Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction |
Q53847534 | Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction. |
Q53617022 | Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials). |
Q81278510 | Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction |
Q52010089 | Association of the Fibonacci Cascade with the distribution of coronary artery lesions responsible for ST-segment elevation myocardial infarction. |
Q34974622 | Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial |
Q37034829 | Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention |
Q44352059 | Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase |
Q80057720 | Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS |
Q53522097 | Bilateral embolic protection devices for high-risk cardiac surgery in a patient with recent embolic stroke. |
Q28281179 | Bivalirudin during primary PCI in acute myocardial infarction |
Q41716870 | Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational database |
Q39388995 | Bleeding Events Before Coronary Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome |
Q88995368 | Bleeding Severity After Percutaneous Coronary Intervention |
Q35610354 | Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention |
Q44068164 | Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). |
Q91675288 | Burden of Valvular Heart Diseases in Hispanic/Latino Individuals in the United States: The Echocardiographic Study of Latinos |
Q81123146 | C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial) |
Q81562997 | CABG surgery versus drug-eluting stent implantation in multivessel disease: an interventional cardiology perspective |
Q51191415 | CASE 11-2016 Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift? |
Q38380438 | COCATS 4 Task Force 13: Training in Critical Care Cardiology |
Q82491369 | Cardiac allograft vasculopathy |
Q91847324 | Cardiac allograft vasculopathy: A review |
Q90575837 | Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic |
Q90566922 | Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC's Interventional Council and SCAI |
Q93135752 | Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy |
Q43759546 | Changes in reference vessel diameter in ST-segment elevation myocardial infarction after primary percutaneous coronary intervention: implications for appropriate stent sizing |
Q87613932 | Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study |
Q47597302 | Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI. |
Q43607711 | Clearing the air on the "smoker's paradox". |
Q57741465 | Clinical Outcomes Using a New Crossover Balloon Occlusion Technique for Percutaneous Closure After Transfemoral Aortic Valve Implantation |
Q94479215 | Clinical Pathway for Management of Suspected or Positive Novel Coronavirus-19 Patients With ST-Segment Elevation Myocardial Infarction |
Q43256615 | Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease |
Q52573656 | Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock. |
Q46834205 | Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings |
Q39629315 | Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies |
Q56977791 | Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis |
Q39117693 | Clinical profile and impact of family history of premature coronary artery disease on clinical outcomes of patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial |
Q37031580 | Clinical use of sirolimus-eluting stents |
Q46678659 | Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events |
Q84700997 | Comparative effectiveness of revascularization strategies |
Q46904308 | Comparative effectiveness of upstream glycoprotein IIb/IIIa inhibitors in patients with moderate- and high-risk acute coronary syndromes: an Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) substudy |
Q93000698 | Comparison Between Traditional and Guide-Catheter Extension Reverse Controlled Antegrade Dissection and Retrograde Tracking: Insights From the PROGRESS-CTO Registry |
Q92572703 | Comparison of Age (<75 Years Vs ≥75 Years) and Platelet Reactivity to the Risk of Thrombotic and Bleeding Events After Successful Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study) |
Q42883088 | Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-corona |
Q89364296 | Comparison of Causes and Associated Costs of 30-Day Readmission of Transcatheter Implantation Versus Surgical Aortic Valve Replacement in the United States (A National Readmission Database Study) |
Q92755116 | Comparison of Incidence and Outcomes of Cardiogenic Shock Complicating Posterior (Inferior) Versus Anterior ST-Elevation Myocardial Infarction |
Q90738813 | Comparison of Percutaneous and Surgical Right Ventricular Assist Device Support After Durable Left Ventricular Assist Device Insertion |
Q87414258 | Comparison of Three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction <40% versus ≥ 40% (from the HORIZONS-AMI trial) |
Q82872483 | Comparison of angiographic and intravascular ultrasonic detection of myocardial bridging of the left anterior descending coronary artery |
Q53582965 | Comparison of biodegradable polymer versus durable polymer sirolimus-eluting stenting in patients with acute st-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the RESOLVE study. |
Q34123999 | Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy). |
Q51209249 | Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome. |
Q44571172 | Comparison of long-term (4-year) outcomes of patients with unprotected left main coronary artery narrowing treated with drug-eluting stents versus coronary-artery bypass grafting |
Q33413571 | Comparison of outcomes in patients with ST-segment elevation myocardial infarction discharged on versus not on statin therapy (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). |
Q28252387 | Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients |
Q53318664 | Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy). |
Q46564787 | Comparison of various scores for predicting success of chronic total occlusion percutaneous coronary intervention. |
Q82994487 | Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardia |
Q92884981 | Competency-Based Assessment of Interventional Cardiology Fellows' Abilities in Intracoronary Physiology and Imaging |
Q40364813 | Completeness of revascularization and its impact on the outcomes of a staged approach of percutaneous coronary intervention followed by minimally invasive valve surgery for patients with concomitant coronary artery and valvular heart disease |
Q26829251 | Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding |
Q41626966 | Contemporary Outcomes of Venoarterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock at a Large Tertiary Care Center. |
Q47102964 | Contrast Utilization During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry |
Q92182310 | Conversation in cardiology: Is there a need for clinical trials for the nonhyperemic pressure ratios? |
Q38886576 | Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. |
Q37459124 | Coronary artery aneurysms after drug-eluting stent implantation |
Q39568683 | Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis). |
Q40917616 | Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: Results from a prospective, single center PCI registry |
Q38614650 | Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial |
Q46000220 | Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE substudy. |
Q79743746 | Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial |
Q88567581 | Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study |
Q41333305 | Cost implications of intraprocedural thrombotic events during PCI. |
Q38501364 | Current controversies over bioresorbable scaffolds |
Q92665542 | Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention |
Q46675604 | Design and rationale of the ANALYZE ST study: a prospective, nonrandomized, multicenter ST monitoring study to detect acute coronary syndrome events in implantable cardioverter-defibrillator patients |
Q61633802 | Development and Validation of a Scoring System for Predicting Periprocedural Complications During Percutaneous Coronary Interventions of Chronic Total Occlusions: The Prospective Global Registry for the Study of Chronic Total Occlusion Intervention ( |
Q91893651 | Device-based therapies for arterial hypertension |
Q26739024 | Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease |
Q94508941 | Diagnostic Performance of Angiography-based Fractional Flow Reserve in Various Subgroups: Report from the FAST-FFR Study |
Q36516029 | Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema |
Q53419376 | Differences in Underlying Culprit Lesion Morphology Between Men and Women: An IVUS Analysis From the ADAPT-DES Study. |
Q46733046 | Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the 'real world'. |
Q44464832 | Direct infusion of fenoldopam into the renal arteries to protect against contrast-induced nephropathy in patients at increased risk |
Q79404162 | Distal embolization of thrombus in acute myocardial infarction |
Q51719870 | Distance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque rupture. |
Q51805744 | Does calcium burden impact culprit lesion morphology and clinical results? An ADAPT-DES IVUS substudy. |
Q88591614 | EC-VAD: Combined Use of Extracorporeal Membrane Oxygenation and Percutaneous Microaxial Pump Left Ventricular Assist Device |
Q57741472 | Early and Late (One Year) Outcomes Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis (from the United States REVIVAL Trial) |
Q80333361 | Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 t |
Q39540449 | Effect of Lesion Age on Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary US Multicenter Registry |
Q36739542 | Effect of Previous Failure on Subsequent Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention (from a Contemporary Multicenter Registry). |
Q38380117 | Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMI: A Secondary Analysis of the HORIZONS-AMI Randomized Clinical Trial |
Q39462063 | Effect of Smoking on Infarct Size and Major Adverse Cardiac Events in Patients With Large Anterior ST-Elevation Myocardial Infarction (from the INFUSE-AMI Trial). |
Q91995607 | Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI |
Q38418337 | Effect of obesity on coronary atherosclerosis and outcomes of percutaneous coronary intervention: grayscale and virtual histology intravascular ultrasound substudy of assessment of dual antiplatelet therapy with drug-eluting stents |
Q57452870 | Effect of orbital atherectomy in calcified coronary artery lesions as assessed by optical coherence tomography |
Q47216847 | Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries |
Q46711890 | Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis |
Q46848569 | Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial I |
Q88871710 | Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial |
Q38398711 | Etiology, Frequency, and Clinical Outcomes of Myocardial Infarction After Successful Drug-Eluting Stent Implantation: Two-Year Follow-Up From the ADAPT-DES Study |
Q79160423 | Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction |
Q93035742 | Factors Associated With and Outcomes of Aborted Procedures During Elective Transcatheter Aortic Valve Replacement |
Q47722489 | Feasibility and Early Safety of Single-Stage Hybrid Coronary Intervention and Valvular Cardiac Surgery |
Q51001316 | Feasibility of smaller arterial cannulas in venoarterial extracorporeal membrane oxygenation. |
Q51058537 | Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial. |
Q36254711 | First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution Study |
Q96166228 | First-in-Human Study of the Saranas Early Bird Bleed Monitoring System for the Detection of Endovascular Procedure-Related Bleeding Events |
Q38402937 | Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES. |
Q95315231 | Follow-up Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With and Without Prior Coronary Artery Bypass Graft Surgery: Insights From the PROGRESS-CTO Registry |
Q91044842 | Frequency and Outcomes of Ad Hoc Versus Planned Chronic Total Occlusion Percutaneous Coronary Intervention: Multicenter Experience |
Q43209404 | Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents |
Q36985650 | Gait speed and dependence in activities of daily living in older adults with severe aortic stenosis |
Q42634785 | Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial |
Q46883865 | Gender-specific outcomes after sirolimus-eluting stent implantation |
Q96291145 | Geographic Access to Transcatheter Aortic Valve Replacement Centers in the United States: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry |
Q46590937 | Guidewire and microcatheter utilization patterns during antegrade wire escalation in chronic total occlusion percutaneous coronary intervention: Insights from a contemporary multicenter registry |
Q89191044 | Habitual Physical Activity: Functional Assessment in Patients With Severe Aortic Stenosis Treated With TAVR |
Q89516509 | Haemodynamic support for cardiogenic shock and high-risk PCI: what can observational data tell us? |
Q92014699 | Hemopericardium and Cardiac Tamponade as a Complication of Vena Caval Filters: Systematic Review of the Published Literature and the MAUDE Database |
Q39425550 | Heparin Versus Bivalirudin in ST-Segment Elevation Myocardial Infarction: A SCAI-Based National Survey From US Interventional Cardiologists |
Q79317346 | Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy |
Q34609578 | How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trial |
Q37930845 | How to minimize stent thrombosis |
Q84927508 | Hypothyroid cardiomyopathy: a reversible form of systolic heart failure |
Q60925347 | IMPACT OF AGE ON OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION IN CHRONIC TOTAL OCCLUSIONS: INSIGHTS FROM A MULTICENTER US REGISTRY |
Q48954077 | Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. |
Q40774686 | Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study |
Q45064792 | Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study |
Q36370689 | Impact of Calcium on Chronic Total Occlusion Percutaneous Coronary Interventions |
Q47929076 | Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction |
Q34486268 | Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials |
Q46262291 | Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study). |
Q90348560 | Impact of Point-of-Care Platelet Function Testing Among Patients With and Without Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study) |
Q50064019 | Impact of Pre-Diabetes on Coronary Plaque Composition and Clinical Outcome in Patients With Acute Coronary Syndromes: An Analysis From the PROSPECT Study |
Q30276003 | Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER Trial |
Q51781001 | Impact of Proximal Cap Ambiguity on Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter US Registry. |
Q91040575 | Impact of Smoking on Platelet Reactivity and Clinical Outcomes After Percutaneous Coronary Intervention: Findings From the ADAPT-DES Study |
Q93192930 | Impact of Subintimal or Plaque Modification on Repeat Chronic Total Occlusion Angioplasty Following an Unsuccessful Attempt |
Q46478102 | Impact of Surgical Consultation on Outcomes in Hemodynamically Supported High-Risk Percutaneous Coronary Intervention: Insights From PROTECT II Randomized Study |
Q44297604 | Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial). |
Q43288786 | Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage str |
Q53476914 | Impact of chronic statin therapy on clinical presentation and underlying lesion morphology in patients undergoing percutaneous intervention: an ADAPT-DES IVUS substudy. |
Q91850864 | Impact of concomitant treatment of non-chronic total occlusion lesions at the time of chronic total occlusion intervention |
Q30988733 | Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction |
Q43732977 | Impact of depressed left ventricular function on outcomes in patients with three-vessel coronary disease undergoing percutaneous coronary intervention. |
Q57169159 | Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stents |
Q91266467 | Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy |
Q56334747 | Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation |
Q91228334 | Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries |
Q94950351 | Impact of the COVID-19 pandemic on interventional cardiology fellowship training in the New York metropolitan area: A perspective from the United States epicenter |
Q34637924 | Impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute coronary syndromes: the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial |
Q44945169 | Impact of the severity of coronary artery calcification on clinical events in patients undergoing coronary artery bypass grafting (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). |
Q90308303 | Impella-assisted chronic total occlusion percutaneous coronary interventions: A multicenter retrospective analysis |
Q38808379 | Implications of Public Reporting of Risk-Adjusted Mortality Following Percutaneous Coronary Intervention: Misperceptions and Potential Consequences for High-Risk Patients Including Nonsurgical Patients |
Q38284058 | Important role of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock |
Q92586201 | Improved survival and cardiovascular outcomes with renin-angiotensin inhibitor use after transcatheter aortic valve replacement |
Q91143032 | Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy |
Q93042499 | Improving Quality for All Patients With Aortic Stenosis |
Q92363699 | In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Prior Coronary Artery Bypass Graft Surgery |
Q92560283 | In-Stent Restenosis Lesion Morphology Related to Repeat Stenting Underexpansion as Evaluated by Optical Coherence Tomography |
Q91366193 | In-hospital Outcomes of Attempting More Than One Chronic Total Coronary Occlusion Through Percutaneous Intervention During the Same Procedure |
Q53109004 | Incentivizing Transradial Access for Primary Percutaneous Coronary Intervention While Maintaining Timely Reperfusion. |
Q38830468 | Incidence and Implications of Left Ventricular Distention During Venoarterial Extracorporeal Membrane Oxygenation Support. |
Q90181228 | Incidence and Outcomes of Surgical Bailout During TAVR: Insights From the STS/ACC TVT Registry |
Q36990354 | Incidence and effect of acute kidney injury after transcatheter aortic valve replacement using the new valve academic research consortium criteria |
Q37987647 | Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses |
Q91320490 | Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry |
Q41445718 | Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention |
Q92638865 | Incidence, Temporal Trends, and Associated Outcomes of Vascular and Bleeding Complications in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Tran |
Q43562497 | Incidence, Treatment, and Outcomes of Coronary Perforation During Chronic Total Occlusion Percutaneous Coronary Intervention. |
Q38838323 | Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized |
Q47650397 | Inferior Vena Cava Filters to Prevent Pulmonary Embolism: Systematic Review and Meta-Analysis |
Q43500037 | Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes |
Q51176352 | Intracoronary bolus administration of eptifibatide during percutaneous coronary stenting for non ST elevation myocardial infarction and unstable angina. |
Q71185472 | Intrapericardial teratoma--a case report |
Q34638192 | Intraprocedural thrombotic events during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes are associated with adverse outcomes: analysis from the ACUITY (Acute Catheterization and Urgent Intervent |
Q38776391 | Intravascular Ultrasound Analysis of Intraplaque Versus Subintimal Tracking in Percutaneous Intervention for Coronary Chronic Total Occlusions and Association With Procedural Outcomes |
Q91043254 | Intravascular Ultrasound Assessment of In-Stent Restenosis in Saphenous Vein Grafts |
Q93192994 | Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility Study |
Q93391094 | Intravascular ultrasound analysis of intraplaque versus subintimal tracking in percutaneous intervention for coronary chronic total occlusions: One year outcomes |
Q54286701 | Intravenous Adenosine-Based Fractional Flow Reserve in Pre-TAVR Assessment of Severe AS: Finally Some Clarity? |
Q46000107 | Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chroni |
Q58089587 | Is There Any Current Role for Bare-Metal Coronary Stents? |
Q40996236 | Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents). |
Q31110506 | Is multivessel intervention in ST-elevation myocardial infarction associated with early harm? Insights from observational data. |
Q40783276 | Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trial |
Q51752013 | Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheteri |
Q38436521 | Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation |
Q43175072 | Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtron |
Q93138887 | Left Main Chronic Total Occlusion Percutaneous Coronary Intervention: A Case Series |
Q50117117 | Left Main Revascularization in 2017: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention? |
Q91738643 | Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement |
Q91591141 | Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock |
Q91141931 | Leveraging the Power of Marginal Gains to Improve Outcomes in Interventional Cardiology |
Q91834766 | Long-Term Outcomes After Revascularization for Stable Ischemic Heart Disease: An Individual Patient-Level Pooled Analysis of 19 Randomized Coronary Stent Trials |
Q91845561 | Long-term (5-year) clinical evaluation of the Resolute zotarolimus-eluting coronary stent: The RESOLUTE US clinical trial |
Q46218015 | Long-term clinical outcomes in patients treated with drug-eluting compared to bare-metal stents for the treatment of transplant coronary artery disease |
Q46738497 | Long-term outcomes after percutaneous coronary intervention of left main coronary artery for treatment of cardiac allograft vasculopathy after orthotopic heart transplantation |
Q37491997 | Long-term outcomes of heart transplantation recipients with transplant coronary artery disease who develop in-stent restenosis after percutaneous coronary intervention. |
Q92084494 | Management of Acute Myocardial Infarction During the COVID-19 Pandemic |
Q93208447 | Management of Acute Myocardial Infarction During the COVID-19 Pandemic |
Q96295354 | Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference |
Q38179176 | Management of multivessel coronary artery disease |
Q52371100 | Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter U.S. Registry. |
Q51729965 | Mechanisms and Patterns of Intravascular Ultrasound In-Stent Restenosis Among Bare Metal Stents and First- and Second-Generation Drug-Eluting Stents. |
Q89713117 | Mechanisms of Orbital Versus Rotational Atherectomy Plaque Modification in Severely Calcified Lesions Assessed by Optical Coherence Tomography |
Q71361926 | Megacystis, microcolon, intestinal hypoperistalsis syndrome: possible pathogenesis |
Q38373158 | Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia |
Q91982285 | Microcatheter-Protected Orbital Atherectomy for Severely Calcified Bifurcation Coronary Artery Disease With Single-Guiding Catheter Technique |
Q38200070 | Minimizing femoral artery access complications during percutaneous coronary intervention: a comprehensive review |
Q88285362 | Morphological Patterns of In-Stent Chronic Total Occlusions: An Intravascular Ultrasound Study |
Q89968518 | Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials |
Q88613275 | Mortality risk after transcatheter aortic valve implantation: analysis of the predictive accuracy of the Transcatheter Valve Therapy registry risk assessment model |
Q38896447 | Mortality, Length of Stay, and Cost Implications of Procedural Bleeding After Percutaneous Interventions Using Large-Bore Catheters |
Q34383952 | Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting Pd/Pa with fractional flow reserve: the RESOLVE study |
Q37473327 | Mutational analysis of NM23-H2/NDP kinase identifies the structural domains critical to recognition of a c-myc regulatory element |
Q50851482 | Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents. |
Q43827461 | Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the NOYA I trial |
Q38662878 | Novel Radiation Dose Reduction Fluoroscopic Technology Facilitates Chronic Total Occlusion Percutaneous Coronary Interventions. |
Q48941781 | Novel minimally invasive surgical approach using an external ventricular assist device and extracorporeal membrane oxygenation in refractory cardiogenic shock |
Q92967503 | Novel percutaneous dual-lumen cannula-based right ventricular assist device provides effective support for refractory right ventricular failure after left ventricular assist device implantation |
Q82644877 | Novel use of the GuideLiner catheter to minimize contrast use during PCI in a patient with chronic kidney disease |
Q57796509 | ORBITA |
Q60925352 | OUTCOMES WITH USE OF THE RETROGRADE APPROACH FOR CORONARY CHRONIC TOTAL OCCLUSION INTERVENTIONS IN A CONTEMPORARY MULTICENTER US REGISTRY |
Q89440171 | One-Year Follow-up of the European Ambulance Acute Coronary Syndrome Angiography Trial |
Q52699615 | Opiate use in the Cath Lab: A transatlantic divide and new focus of research. |
Q44528998 | Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ΙΙ study |
Q47637154 | Orbital atherectomy for the treatment of severely calcified coronary lesions: evidence, technique, and best practices |
Q53215061 | Outcomes After Successful Percutaneous Coronary Intervention of Calcified Lesions Using Rotational Atherectomy, Cutting-Balloon Angioplasty, or Balloon-Only Angioplasty Before Drug-Eluting Stent Implantation. |
Q37015795 | Outcomes With the Use of the Retrograde Approach for Coronary Chronic Total Occlusion Interventions in a Contemporary Multicenter US Registry |
Q95923880 | Outcomes of Patients Bridged with Acute Mechanical Circulatory Support Devices to HeartMate 3 |
Q36250548 | Outcomes of a Combined Approach of Percutaneous Coronary Revascularization and Cardiac Valve Surgery |
Q91636281 | Outcomes of patients with right ventricular failure requiring short-term hemodynamic support with the Impella RP device |
Q39171472 | Outcomes of stenting extra-small (≤2.25 mm) vessels using the Resolute zotarolimus-eluting stent (R-ZES). |
Q38441489 | Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). |
Q36154232 | Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials. |
Q60925364 | PREVALENCE, INDICATIONS AND MANAGEMENT OF BALLOON UNCROSSABLE CHRONIC TOTAL OCCLUSIONS: INSIGHTS FROM A CONTEMPORARY MULTICENTER US REGISTRY |
Q47908774 | Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials |
Q37031505 | Patient radiation exposure during transcatheter aortic valve replacement procedures |
Q38107887 | Patients who require non-cardiac surgery in acute coronary syndrome |
Q38777195 | Percutaneous Coronary Intervention With Bioresorbable Scaffolds in a Young Child. |
Q38376910 | Percutaneous Coronary Intervention of Saphenous Vein Graft |
Q47711302 | Percutaneous coronary intervention of bifurcation lesions and platelet reactivity |
Q49972170 | Percutaneous coronary intervention of lesions with in-stent restenosis: A report from the ADAPT-DES study |
Q94456575 | Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction |
Q53253517 | Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention--From the PROTECT II randomized trial. |
Q96028621 | Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research |
Q64103444 | Physical Activity After Percutaneous Coronary Intervention for Chronic Total Occlusion and Its Association With Health Status |
Q38379501 | Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents). |
Q89125284 | Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study |
Q38153573 | Platelet function and genetic testing. |
Q41968141 | Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study |
Q89679903 | Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk |
Q51364291 | Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. |
Q38433830 | Post-PCI Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation |
Q85345619 | Postprocedural anticoagulation for specific therapeutic indications after revascularization for ST-segment elevation myocardial infarction (from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial) |
Q45066266 | Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United States |
Q38000673 | Practices and complications of vascular closure devices and manual compression in patients undergoing elective transfemoral coronary procedures |
Q89733269 | Practicing Art in Clinical Medicine: Clinical Commentary on "It Happened So Fast... I Guess, Yes, I Was Lucky" |
Q36407121 | Predictable and SuStainable Implementation of National Cardiovascular Registries (PASSION) infrastructure: A think tank report from Medical Device Epidemiological Network Initiative (MDEpiNet) |
Q44264392 | Predicting paravalvular regurgitation following transcatheter valve replacement: utility of a novel method for three-dimensional echocardiographic measurements of the aortic annulus |
Q57818728 | Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population |
Q38128135 | Prediction of coronary risk by SYNTAX and derived scores: synergy between percutaneous coronary intervention with taxus and cardiac surgery |
Q30366121 | Predictors and Long-Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) Intravascular Ultrasound Substudy. |
Q40346679 | Predictors of Excess Patient Radiation Exposure During Chronic Total Occlusion Coronary Intervention: Insights From a Contemporary Multicentre Registry. |
Q57479596 | Predictors of Survival for Patients with Acute Decompensated Heart Failure Requiring Extra-Corporeal Membrane Oxygenation Therapy |
Q34343316 | Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial. |
Q47388957 | Predictors of survival and ability to wean from short-term mechanical circulatory support device following acute myocardial infarction complicated by cardiogenic shock. |
Q88697147 | Pressure wire compared to microcatheter sensing for coronary fractional flow reserve: the PERFORM study |
Q51222402 | Prevalence and Clinical Impact of Tissue Protrusion After Stent Implantation: An ADAPT-DES Intravascular Ultrasound Substudy. |
Q57053154 | Prevalence and Outcomes of Percutaneous Coronary Interventions for Ostial Chronic Total Occlusions: Insights From a Multicenter Chronic Total Occlusion Registry |
Q38410176 | Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registry |
Q38390273 | Prevalence, Features, and Prognostic Importance of Edge Dissection After Drug-Eluting Stent Implantation: An ADAPT-DES Intravascular Ultrasound Substudy |
Q88888403 | Prevalence, predictors, and health status implications of periprocedural complications during coronary chronic total occlusion angioplasty |
Q91738616 | Procedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach: Insights From an International Chronic Total Occlusion Registry |
Q53665698 | Procedural variation in the performance of primary percutaneous coronary intervention for ST-elevation myocardial infarction: a SCAI-based survey study of US interventional cardiologists. |
Q90647004 | Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies |
Q38475716 | Prognostic significance of elevated baseline troponin in patients with acute coronary syndromes and chronic kidney disease treated with different antithrombotic regimens: a substudy from the ACUITY trial |
Q38413975 | Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy |
Q64075566 | Prospective Comparison of a Percutaneous Ventricular Assist Device and Venoarterial Extracorporeal Membrane Oxygenation for Patients With Cardiogenic Shock Following Acute Myocardial Infarction |
Q38402115 | Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study |
Q40103494 | Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study). |
Q90368128 | Quantitative flow ratio-guided strategy versus angiography-guided strategy for percutaneous coronary intervention: Rationale and design of the FAVOR III China trial |
Q90044798 | RESPONSE: CHIP Training: Thinking Beyond the Numbers |
Q50096167 | Race/Ethnicity-Based Outcomes in Cardiovascular Medicine |
Q50154495 | Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial |
Q37587486 | Rat model of veno-arterial extracorporeal membrane oxygenation. |
Q91462752 | Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention |
Q92773863 | Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy |
Q91919500 | Re-wire but don't necessarily kiss twice for bifurcations treated with two stents: The DR-crush technique |
Q90832082 | Real world validation of the nonhyperemic index of coronary artery stenosis severity-Resting full-cycle ratio-RE-VALIDATE |
Q44662878 | Rebuttal: "Closure of patent foramen ovale and prevention of recurrent thromboembolic events". |
Q87235792 | Rebuttal: "a critical appraisal of a meta-analysis comparing transcatheter closure of PFO versus medical therapy" |
Q95550667 | Redesigning Care for Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock: The "Shock Team" |
Q40806431 | Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study |
Q47954675 | Relation Between Renal Function and Coronary Plaque Morphology (from the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Virtual Histology-Intravascular Ultrasound Substudy). |
Q46966155 | Relation between coronary calcium and major bleeding after percutaneous coronary intervention in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy and Harmonizing Outcomes With Revascularization and Ste |
Q37100880 | Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial) |
Q92374627 | Relation of Postdischarge Care Fragmentation and Outcomes in Transcatheter Aortic Valve Implantation from the STS/ACC TVT Registry |
Q35762964 | Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial) |
Q42644667 | Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction |
Q90666866 | Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents |
Q51507336 | Relationship Between Platelet Reactivity and Culprit Lesion Morphology: An Assessment From the ADAPT-DES Intravascular Ultrasound Substudy. |
Q93168012 | Relationship Between Stent Diameter, Platelet Reactivity, and Thrombotic Events After Percutaneous Coronary Artery Revascularization |
Q46754031 | Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial |
Q87307993 | Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right |
Q53405590 | Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right. |
Q42345826 | Renal denervation for the treatment of hypertension: If at first you don't succeed, try and try again |
Q48453071 | Renal denervation for the treatment of hypertension: Making a new start, getting it right |
Q89548528 | Reply: Characteristic Left Ventricular Regional Wall Motion Abnormality Can Help Prevent Unnecessary Ischemic Workup |
Q48538195 | Reply: Clinical Significance of Intravascular Ultrasound-Detected Vascular Injury Following Chronic Total Occlusion Recanalization With Intraplaque Versus Subintimal Tracking Techniques |
Q92729394 | Reply: Left Ventricle Unloading Strategy: Which One Is More Effective in Venoarterial Extracorporeal Membrane Oxygenation Patients? |
Q53564995 | Reply: Routine Ischemic Work-Up for Patients With New-Onset Heart Failure. |
Q51462278 | Response to Letter Regarding Article, "Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study". |
Q93178488 | Restructuring Electrophysiology During the COVID-19 Pandemic: A Practical Guide from a New York City Hospital Network |
Q50016158 | Retrograde CTO-PCI of Native Coronary Arteries Via Left Internal Mammary Artery Grafts: Insights From a Multicenter U.S. Registry |
Q89815932 | Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via Saphenous Vein Graft |
Q89370220 | Retrograde approach to an ostial left anterior descending chronic total occlusion through a left internal mammary artery graft |
Q36888098 | Revascularization in heart failure: the role of percutaneous coronary intervention |
Q37146054 | Revascularization of unprotected left main coronary artery disease with percutaneous coronary intervention: the role of drug-eluting stents. |
Q47631740 | Role of Hospital Volumes in Identifying Low-Performing and High-Performing Aortic and Mitral Valve Surgical Centers in the United States. |
Q41501280 | Role of enhanced Na+ entry in the control of Na,K-ATPase gene expression by serum |
Q94678349 | SCAI Position Statement on Optimal Percutaneous Coronary Interventional Therapy for Complex Coronary Artery Disease |
Q88163921 | STEMI care in China: a world opportunity |
Q39764608 | Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: From the REPLACE-2, ACUITY and HORIZONS-AMI Trials |
Q91756914 | Safety and efficacy of bivalirudin monotherapy in patients with non-ST-segment elevation acute coronary syndromes with positive biomarkers undergoing percutaneous coronary intervention: a report from the Acute Catheterization and Urgent Intervention |
Q53057713 | Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. |
Q50176817 | Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents |
Q43967182 | Same-day discharge or overnight stay after percutaneous coronary intervention: comparison of net adverse cardiovascular events |
Q37919637 | Saphenous vein graft intervention |
Q85121343 | Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial |
Q80942033 | Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction |
Q46528607 | Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates |
Q90565806 | Severe coronary artery spasm presenting as Prinzmetal's angina following cardiac transplantation |
Q38380899 | Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents). |
Q50229683 | Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study |
Q39978024 | Sex-Specific Differences at Presentation and Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement: A Cohort Study |
Q47557721 | Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts |
Q51158696 | Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve). |
Q92855940 | Sham-Controlled Randomized Trials of Catheter-Based Renal Denervation in Patients With Hypertension |
Q36102874 | Sharing Data from Cardiovascular Clinical Trials--A Proposal |
Q39434488 | Shedding blood: anemia and adverse events after percutaneous coronary intervention (PCI). |
Q46834201 | Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era. |
Q50149110 | Should We Up the Intensity of Statin Therapy After Placing a Drug-eluting Stent |
Q87357717 | Should all stent patients have prolonged dual antiplatelet therapy? |
Q92423092 | Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial |
Q44840220 | Stent thrombosis after successful sirolimus-eluting stent implantation |
Q37996688 | Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. |
Q38016250 | Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials |
Q89711644 | Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention |
Q52330465 | Stenting in Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction. |
Q37955347 | Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review |
Q95926523 | Successful Use of Veno-Arterial Extracorporeal Membrane Oxygenation as a Bridging Strategy in INTERMACS 1 Patients Undergoing HeartMate 3 LVAD Implantation |
Q38410814 | Surgical versus percutaneous coronary revascularization for multivessel disease in diabetic patients with non-ST-segment-elevation acute coronary syndrome: analysis from the Acute Catheterization and Early Intervention Triage Strategy trial |
Q40227677 | Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. |
Q52630780 | Systematic review of efficacy and safety of retrievable inferior vena caval filters. |
Q90955506 | TAVR After Prior Mitral Valve Surgery: Results from the Transcatheter Valve Therapy Registry |
Q57458444 | TCT-308 Impact of Race and Ethnicity on Technical and In-Hospital Outcomes Following Chronic Total Occlusions Percutaneous Coronary Intervention |
Q57741397 | TCT-674 Sex Specific Outcomes of TAVR with the Sapien 3 Valve: Insights From The PARTNER 2 S3 High-Risk and Intermediate-Risk Cohorts |
Q57741401 | TCT-691 Sex-Specific Differences After Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients: An Analysis from the PARTNER 2 Randomized Trial |
Q88644359 | Temporal Trends and Factors Associated With Prolonged Length of Stay in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention |
Q90542450 | Temporal Trends in Chronic Total Occlusion Percutaneous Coronary Interventions: Insights From the PROGRESS-CTO Registry |
Q36673541 | Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy. |
Q81415387 | Temporal changes in TIMI myocardial perfusion grade in relation to epicardial flow, ST-resolution and left ventricular function after primary percutaneous coronary intervention |
Q51796471 | Temporal variability in the antiplatelet effects of clopidogrel and aspirin after elective drug-eluting stent implantation. An ADAPT-DES substudy. |
Q46358602 | The "final" 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent |
Q51003816 | The Anchor-Tornus technique: a novel approach to "uncrossable" chronic total occlusions. |
Q88138564 | The Changing Paradigm for Assessment of Ischemic Coronary Artery Disease |
Q48047251 | The Complicated Calculus of Publicly Reporting Mortality After Percutaneous Coronary Intervention |
Q92886517 | The Effect and Relationship of Frailty Indices on Survival After Transcatheter Aortic Valve Replacement |
Q88506448 | The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: Update From the PROGRESS CTO Registry |
Q50952167 | The Impact of Age and Sex on In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention. |
Q92037188 | The Impact of Peripheral Artery Disease in Chronic Total Occlusion Percutaneous Coronary Intervention (Insights From PROGRESS-CTO Registry) |
Q50608613 | The Impact of Proximal Vessel Tortuosity on the Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry. |
Q45935378 | The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES Study. |
Q91861735 | The Importance of Listening to Patients: The Seattle Angina Questionnaire |
Q53554372 | The Importance of Long-term Follow-up Within Randomized Clinical Trials of Cardiovascular Devices. |
Q38021687 | The Placement of Aortic Transcatheter Valve (PARTNER) trial: clinical trialist perspective |
Q89815920 | The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension |
Q91828155 | The Restructuring of Structural Heart Disease Practice During The Covid-19 Pandemic |
Q48901653 | The SYNTAX Score Does Not Predict Risk of Adverse Events in Patients With Non-ST Elevation Acute Coronary Syndrome Who Undergo Coronary Artery Bypass Graft Surgery |
Q91648257 | The Use of AngioVac Thrombectomy in IVC Filter-Associated IVC Thrombosis |
Q91531355 | The Variety of Cardiovascular Presentations of COVID-19 |
Q95623283 | The association between the extent of coronary artery disease and major bleeding events after percutaneous coronary intervention: from the ACUITY trial |
Q85564776 | The benefit of ischemia-based revascularization for stable ischemic heart disease: the impact of FAME 2 |
Q87322399 | The end of ENDEAVOR IV: the stent comparison trial's final follow-up |
Q24596908 | The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience |
Q49819909 | The influence of advanced age on venous-arterial extracorporeal membrane oxygenation outcomes |
Q87154235 | The quickening path ahead for renal denervation therapies? |
Q30458103 | The relative performance characteristics of the logistic European System for Cardiac Operative Risk Evaluation score and the Society of Thoracic Surgeons score in the Placement of Aortic Transcatheter Valves trial |
Q85502738 | The utility of a 5-in-6 double catheter technique in treating complex coronary lesions via transradial approach: the DOCA-TRI study |
Q49791362 | Thirty-Day Readmission Rate and Costs After Percutaneous Coronary Intervention in the United States: A National Readmission Database Analysis |
Q41523087 | Transapical and Transaortic Transcatheter Aortic Valve Replacement in the United States |
Q44259433 | Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial |
Q91616328 | Transcatheter Cardiovascular Therapeutics 2018 |
Q38417819 | Transcatheter aortic valve replacement and standard therapy in inoperable patients with aortic stenosis and low EF. |
Q37656312 | Transcatheter versus surgical aortic valve replacement in patients with diabetes and severe aortic stenosis at high risk for surgery: an analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve). |
Q38835461 | Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention |
Q53201137 | Trends in Complications and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Experience From the PARTNER Continued Access Registry. |
Q92884998 | Trends in Usage and Clinical Outcomes of Coronary Atherectomy: A Report From the National Cardiovascular Data Registry CathPCI Registry |
Q46404723 | Triage of patients with acute chest pain and possible cardiac ischemia: the elusive search for diagnostic perfection |
Q50979607 | Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents. |
Q46578828 | U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction |
Q92069313 | Ultra-low-contrast angiography in patients with advanced chronic kidney disease and previous coronary artery bypass surgery |
Q88018530 | Underutilization of Coronary Artery Disease Testing Among Patients Hospitalized With New-Onset Heart Failure |
Q34644302 | Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document |
Q87396274 | Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document |
Q87410383 | Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document |
Q95423935 | Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document |
Q38048557 | Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). |
Q86850189 | Updates to the ACCF/AHA and ESC STEMI and NSTEMI guidelines: putting guidelines into clinical practice |
Q93175641 | Upstream Impact of Public Reporting |
Q91849893 | Uptake of Drug-Eluting Bioresorbable Vascular Scaffolds in Clinical Practice: An NCDR Registry to Practice Project |
Q39192624 | Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States |
Q37240474 | Use of Intravascular Imaging During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry. |
Q36889216 | Use of antegrade dissection re-entry in coronary chronic total occlusion percutaneous coronary intervention in a contemporary multicenter registry |
Q91864702 | Usefulness of Atherectomy in Chronic Total Occlusion Interventions (from the PROGRESS-CTO Registry) |
Q53020656 | Utility of near-infrared spectroscopy for detection of thin-cap neoatherosclerosis. |
Q47976208 | Validation Study of Image-Based Fractional Flow Reserve During Coronary Angiography |
Q38434888 | Validation of residual SYNTAX score with second-generation drug-eluting stents: one-year results from the prospective multicentre SEEDS study |
Q46115333 | Value of drug-eluting stents in cardiac transplant recipients |
Q51768641 | Variability in maximal suggested door-in-door-out time for hospitals transferring patients for primary angioplasty in STEMI. |
Q57176688 | Variation in post-TAVR antiplatelet therapy utilization and associated outcomes: Insights from the STS/ACC TVT Registry |
Q36842487 | Vascular endothelial growth factors in pulmonary edema: an update. |
Q92183909 | When Can Strut Thickness Really Matter in Percutaneous Coronary Intervention? |
Q82328436 | When is better not good enough?: Insights from the COURAGE economic study |
Q40955307 | Which Intraprocedural Thrombotic Events Impact Clinical Outcomes After Percutaneous Coronary Intervention in Acute Coronary Syndromes?: A Pooled Analysis of the HORIZONS-AMI and ACUITY Trials |
Search more.